Deadly fungus tied to a pharaoh’s tomb may help fight cancer – 1v1 Video Chat & LIve Streaming & Influencer Subscription

SUBSCRIBE & SAVE

Less than $3 per week

View Profile

The Explainer

Talking Points

The Week Recommends

Newsletters

From the Magazine

The Week Junior

Food & Drink

Personal Finance

All Categories

Newsletter sign up

under the radar

Deadly fungus tied to a pharaoh’s tomb may help fight cancer

A once fearsome curse could be a blessing

Newsletter sign up

The Aspergillus flavus fungus contains molecules that can effectively fight leukemia cancer cells

(Image credit: Illustration by Julia Wytrazek / Getty Images)

Devika Rao, The Week US

27 June 2025

A fatal fungus once thought to be a curse could potentially help fight disease. Scientists discovered molecules in a fungus linked to Tutankhamun’s tomb that stop the proliferation of cancer cells and are as effective as currently used treatments. Fungi may hold a treasure trove of medical breakthroughs just waiting to be unearthed.

Treatment from beyond the grave
The “pharaoh’s curse” fungus, Aspergillus flavus, can be used to fight leukemia, according to a study published in the journal Nature Chemical Biology. The fungus is called “pharaoh’s curse” because it is “linked to the deaths of several archeologists who opened ancient tombs around the world, including the famous discovery of the Tomb of Tutankhamun in the 1920s,” said Popular Mechanics. At the time, many believed the deaths to be the result of an ancient curse rather than fungal inhalation.
Aspergillus flavus is known as a “microbial villain,” said Popular Science. It is “one of the most frequently isolated mold species in both agriculture and medicine,” and is “commonly found in soil and can infect a broad range of important agricultural crops.” Exposure to the fungus can lead to lung infections, especially in those who are immunocompromised. Despite its deadly reputation, the fungus contains a class of peptides that can fight cancer when modified.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Researchers were able to isolate four molecules from A. flavus, which they named “asperigimycins.” The molecules were capable of forming a unique structure of interlocking rings. “Even without genetic modifications, the asperigimycins demonstrated medical potential when mixed together with human cancer cells,” said Popular Science. “Two out of the four variants had potent effects against leukemia cells.” When fatty molecules called lipids were added to the mix, the asperigimycins were as effective as the FDA-approved drugs used to treat the cancer. There also seem to be no apparent side effects from A. flavus.

Fungus among us
Asperigimycins are part of a class of molecules called ribosomally synthesized and post-translationally modified peptides, or RiPPs. A number of them have been found in bacteria, but they are “rare in fungi and notoriously hard to study,” said Wired. This is “mainly because no one was looking closely until now.” However, “even though only a few have been found, almost all of them have strong bioactivity,” Qiuyue Nie, a postdoctoral fellow at the University of Pennsylvania and an author of the study, said in a statement. “This is an unexplored region with tremendous potential.”
Fungi have long been a source of medicine, perhaps most famously the antibiotic penicillin. This research implies there is more where that came from. “Nature has given us this incredible pharmacy,” Sherry Gao, an associate professor at UPenn and the senior author of the study, said in the statement. “It’s up to us to uncover its secrets. As engineers, we’re excited to keep exploring, learning from nature and using that knowledge to design better solutions.” The next step in the process will be to test the newly discovered treatment on animals and then eventually on humans. It will likely still be many years before the treatments can be widely used on people.

Explore More

Sign up for Today’s Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Contact me with news and offers from other Future brandsReceive email from us on behalf of our trusted partners or sponsorsBy submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.

Devika Rao, The Week US

Social Links Navigation

Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.

Codeword: June 27, 2025

The Week’s daily codeword puzzle

Sudoku medium: June 27, 2025

The Week’s daily medium sudoku puzzle

Sudoku hard: June 27, 2025

The Week’s daily hard sudoku puzzle